<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>Acknowledgements</title>
 <p>The authors thank the participants and the community of Mbongolwane and Eshowe for their collaboration. We are grateful to the Epicentre study field team for their work and the Médecins Sans Frontières field team for their support. Special mention to Serge Balandine for his work using satellite maps for sampling and creating the database; Madurai S and the rest of Global Clinical and Viral laboratories team for their collaboration and work performing part of the laboratory tests. We thank Ahidjo Ayouba for his advice on the manuscript. The Division of Clinical Pharmacology at the University of Cape Town was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1 AI068634, UM1 AI068636 and UM1 AI106701. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p>
 <sec id="FPar1">
  <title>Funding</title>
  <p id="Par37">This study was funded by Médecins Sans Frontières. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
  <p id="Par38">Qualitative testing for ARV drug levels reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1 AI068634, UM1 AI068636 and UM1 AI106701. Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI068632], the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institute of Mental Health (NIMH) [AI068632]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p>
 </sec>
 <sec id="FPar2">
  <title>Availability of data and materials</title>
  <p id="Par39">The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p>
 </sec>
</ack>
